newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Reports Third Quarter Financial Results and Business Highlights

TORRANCE, Calif., Nov. 12, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported financial results for the quarter and nine months en